Dementia

Crain’s Chicago Business Names Steve Satek One of Chicago’s Notable LGBTQ Executives

Chicago, IL – Great Lakes Clinical Trials Founder and President, Steve Satek, is one of Crain's Chicago Business’ Chicago's Notable LGBTQ Executives 2018.

Satek is being recognized for, among other things, his leadership at Great Lakes Clinical Trials which has greatly contributed to it being one of Chicago’s leading clinical research centers.  Great Lakes Clinical Trials was established on the principle of making clinical study opportunities more convenient and comfortable for patients.  This means providing easily accessible locations within neighborhood communities, including Andersonville and Arlington Heights, as well as creating a welcoming atmosphere to patients of all backgrounds, ages and sexual orientations.

Steve Satek, President Great Lakes Clinical Trials 

Steve Satek, President
Great Lakes Clinical Trials 

Alzheimer’s disease and memory loss are key areas of research for Satek and the team at Great Lakes Clinical Trials. “In recent years we have made good progress towards a cure,” commented Mr. Satek. “There are often a lot of uncertainties in research, but one thing we know for sure is that we will never have a new medication to help treat or prevent Alzheimer’s disease without the participation of older adults in our current research trials.”

By 2030, there will be nearly five million adults aged 60 and older in the U.S. who identify as lesbian, gay, or bisexual.  As advanced age is a key risk factor or Alzheimer’s, Satek has created a community-based, LGBTQ-friendly center where volunteers and care partners can comfortably participate in clinical trials.

“At Great Lakes Clinical Trials, we are patient focused.  We do not see color, race, religion or sexual orientation, but rather we see neighbors, friends and our community,” added Satek.  “Diversity is one of the things I cherish most about growing up and living in the Chicago area.  We are all equals, and I could not be prouder to be recognized for the welcoming culture established at Great Lakes Clinical Trials.”

The research center led by Satek recently joined the Global Alzheimer’s Platform (GAP) Foundation’s invitation only national network of the leading clinical trial sites in Alzheimer’s research. On learning of the Crain’s announcement,  GAP’s president, John Dwyer said, “GAP congratulates Crain’s excellent judgement in selecting Steve as one of Chicago’s Notable LGBTQ Executives. Steve is one of the passionate, dedicated leaders in Alzheimer’s research and shares our commitment to providing access to Alzheimer’s clinical trials to anyone interested in finding a cure for this invidious disease--a disease that does not discriminate on the basis of sex, race, religion or sexual orientation.  Alzheimer’s research and Chicago are lucky to have Steve Satek and Great Lakes Clinical Trials in this fight; the recognition of his leadership is very much deserved.”

For more information about the ongoing research at Great Lakes Clinical Trials, visit: greatlakesclinicaltrials.com.

The announcement was made in Crain’s August 27th print edition as well as online at ChicagoBusiness.com.  This section profiles Chicago's notable LGBTQ executives, specifically those who are advancing their industries and/or workplace equality.

About Great Lakes Clinical Trials

Great Lakes Clinical Trials is an independent, community-based research clinic.  With two Chicago area locations in Andersonville and in Arlington Heights, the Great Lakes team have managed more than 525 clinical trials over the past 25 years and are committed to providing quality services for both study volunteers & the research industry. Great Lakes Clinical Trials specializes in the study of investigational medications, food products, devices and supplements for the treatment of chronic diseases, notably in Mental Health, Memory Disorders, Pain Management, Nutrition and Dermatology. For more information, please visit http://www.greatlakesclinicaltrials.com/.

Contact

To learn more or to inquire about interviews, please contact:
Steve Malito, Media Relations
Great Lakes Clinical Trials
Office: (773) 275-3500
Fax: (773) 275-3501
info@greatlakesclinicaltrials.com

Steve Satek Presents A Lecture Entitled "Embracing the Future of Alzheimer's Disease"

Steve Satek, Co-Founder of Great Lakes Clinical Trials

Steve Satek, Co-Founder of Great Lakes Clinical Trials

As part of the free Alzheimer’s Research: Get Informed, Get Involved lecture series sponsored by the Alzheimer's Association Greater Illinois Chapter, Steve Satek, President and Co-Founder of Great Lakes Clinical Trials will be presenting a lecture entitled "Embracing the Future of Alzheimer's Disease". The event will take place on Thursday May 4, 2017 from 2:00-3:00 p.m

"I'm proud to be involved in this lecture series," commented Mr. Satek, who also serves on the Alzheimer's Association Greater Illinois Chapter Medical & Scientific Advisory Board. "These programs provide the opportunity to discuss current trends, efforts and directions in dementia research. We are making great strides in Alzheimer's research and these presentation are a means to get the word out to those who want to make a difference in finding a prevention or cure." 

This dynamic presentation will provide the latest updates on Alzheimer's research and discuss the impact of clinical trials on the future of treatments. Join us to learn about the latest updates on Alzheimer's research, including:

• Current efforts to fight Alzheimer's disease in your community
• The role research plays in developing the next generation of treatments
• Explore the benefits of being a study participant; Engage in TrialMatch®
 

The Alzheimer's Association will also be on site to provide an overview of services and each participant will receive access to the Alzheimer's Association's TrialMatch® registry.

The event will be hosted by Loyola Gottlieb Memorial Hospital, Professional Office Building Room E, F & G, located at 701 W. North Ave in Melrose Park, IL.   Registration is required for this FREE series - to RSVP, call 847.324.0393 or email hjohnson@alz.org

To download a copy of the event flyer click HERE

 

Steve Satek Accepts Committee Appointment with the Alzheimer's Association

Steve Satek, Great Lakes Clinical Trials President, is proud to have accepted an invitation to participate on the Alzheimer's Association, Greater Illinois Chapter, Medical and Scientific Advisory Committee for 2016.

"I am truly honored to accept this position," commented Mr. Satek.  "Our Great Lakes Clinical Trial research team has worked tirelessly to fulfill our mission of educating the people of Chicagoland about the exciting developments in Alzheimer's disease research.  The Alzheimer's Association has been an amazing leader in this area and I look forward to collaborating to expand the outreach and message across our State."

The services of the Alzheimer's Association, Greater Illinois Chapter, rank at the top in the nation and serve as the national model in many instances. Illinois is among the states with the highest estimated number of people with Alzheimer's disease, currently at 210,000.  By the year 2025, it is projected that Illinois will have 260,000 people with Alzheimer's - up by 24 percent over current numbers.  In 2016, our Chapter is committed more than ever to inform, educate, support and provide hope to all throughout Illinois who are affected by dementia.

If you or a loved one are interested in learning more about participation in Alzheimer's disease research studies, please call Great Lakes Clinical Trials at (773) 275-3500 or visit our website at www.greatlakesclinicaltrials.com